Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Compass Therapeutics Shares Drop After Downgrade From Wedbush

Compass Therapeutics Shares Drop After Downgrade From Wedbush

MT newswireMT newswire2026/09/23 18:18
02:18 PM EDT, 09/23/2026 (MT Newswires) -- Compass Therapeutics (CMPX) shares were down nearly 7% on Wednesday after Wedbush downgraded the company's stock to neutral from outperform and cut the price target to $1 from $5. Trading volume stood at more than 4.7 million shares against a daily average of around 3.3 million. Price: 1.16, Change: -0.09, Percent Change: -6.85
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Overseas capital is aggressively buying US stocks! Net inflows reached $942 billions over the past 12 months, marking a record since 1985.

According to data from the US Department of the Treasury, in the 12 months ending July this year, overseas investors made net purchases of US stocks totaling $942 billion, marking the highest rolling 12-month total since records began in 1985. The net purchases in the second quarter alone reached $426 billion, setting a new single-quarter record. Meanwhile, overseas demand for US Treasuries has noticeably cooled, with purchase volumes falling significantly. As a result, the US is facing higher costs in government debt financing.

华尔街见闻•2026/09/26 11:36